Log in to save to my catalogue

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative...

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5931111

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes

About this item

Full title

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes

Publisher

London: Nature Publishing Group UK

Journal title

British journal of cancer, 2018-04, Vol.118 (8), p.1115-1122

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Breast cancer (BC) is a heterogeneous disease characterised by variant biology, metabolic activity and patient outcome. This study aimed to evaluate the biological and prognostic value of the membrane solute carrier, SLC3A2 in BC with emphasis on the intrinsic molecular subtypes. SLC3A2 was assessed at the genomic level, using METABRIC data (
n<...

Alternative Titles

Full title

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5931111

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5931111

Other Identifiers

ISSN

0007-0920,1532-1827

E-ISSN

1532-1827

DOI

10.1038/s41416-018-0038-5

How to access this item